BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 30605742)

  • 21. The Genetics of Uveal Melanoma: Overview and Clinical Relevance.
    Riechardt AI; Kilic E; Joussen AM
    Klin Monbl Augenheilkd; 2021 Jul; 238(7):773-780. PubMed ID: 34376007
    [TBL] [Abstract][Full Text] [Related]  

  • 22. SF3B1 and BAP1 mutations in blue nevus-like melanoma.
    Griewank KG; Müller H; Jackett LA; Emberger M; Möller I; van de Nes JA; Zimmer L; Livingstone E; Wiesner T; Scholz SL; Cosgarea I; Sucker A; Schimming T; Hillen U; Schilling B; Paschen A; Reis H; Mentzel T; Kutzner H; Rütten A; Murali R; Scolyer RA; Schadendorf D
    Mod Pathol; 2017 Jul; 30(7):928-939. PubMed ID: 28409567
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genetic landscape of uveal melanoma.
    Rodrigues MJ; Stern MH
    J Fr Ophtalmol; 2015 Jun; 38(6):522-5. PubMed ID: 25976133
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mutation frequencies of GNAQ, GNA11, BAP1, SF3B1, EIF1AX and TERT in uveal melanoma: detection of an activating mutation in the TERT gene promoter in a single case of uveal melanoma.
    Dono M; Angelini G; Cecconi M; Amaro A; Esposito AI; Mirisola V; Maric I; Lanza F; Nasciuti F; Viaggi S; Gualco M; Bandelloni R; Truini M; Coviello DA; Zupo S; Mosci C; Pfeffer U
    Br J Cancer; 2014 Feb; 110(4):1058-65. PubMed ID: 24423917
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combined mutation and copy-number variation detection by targeted next-generation sequencing in uveal melanoma.
    Smit KN; van Poppelen NM; Vaarwater J; Verdijk R; van Marion R; Kalirai H; Coupland SE; Thornton S; Farquhar N; Dubbink HJ; Paridaens D; de Klein A; Kiliç E
    Mod Pathol; 2018 May; 31(5):763-771. PubMed ID: 29327717
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Integrative Analysis Identifies Four Molecular and Clinical Subsets in Uveal Melanoma.
    Robertson AG; Shih J; Yau C; Gibb EA; Oba J; Mungall KL; Hess JM; Uzunangelov V; Walter V; Danilova L; Lichtenberg TM; Kucherlapati M; Kimes PK; Tang M; Penson A; Babur O; Akbani R; Bristow CA; Hoadley KA; Iype L; Chang MT; ; Cherniack AD; Benz C; Mills GB; Verhaak RGW; Griewank KG; Felau I; Zenklusen JC; Gershenwald JE; Schoenfield L; Lazar AJ; Abdel-Rahman MH; Roman-Roman S; Stern MH; Cebulla CM; Williams MD; Jager MJ; Coupland SE; Esmaeli B; Kandoth C; Woodman SE
    Cancer Cell; 2017 Aug; 32(2):204-220.e15. PubMed ID: 28810145
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multi-Modality Analysis Improves Survival Prediction in Enucleated Uveal Melanoma Patients.
    Drabarek W; Yavuzyigitoglu S; Obulkasim A; van Riet J; Smit KN; van Poppelen NM; Vaarwater J; Brands T; Eussen B; Verdijk RM; Naus NC; Mensink HW; Paridaens D; Boersma E; van de Werken HJG; Kilic E; de Klein A;
    Invest Ophthalmol Vis Sci; 2019 Aug; 60(10):3595-3605. PubMed ID: 31425584
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recent developments in prognostic and predictive testing in uveal melanoma.
    Field MG; Harbour JW
    Curr Opin Ophthalmol; 2014 May; 25(3):234-9. PubMed ID: 24713608
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Metastatic Disease in Polyploid Uveal Melanoma Patients Is Associated With BAP1 Mutations.
    Yavuzyigitoglu S; Mensink HW; Smit KN; Vaarwater J; Verdijk RM; Beverloo B; Brüggenwirth HT; van Marion R; Dubbink HJ; Paridaens D; Naus NC; de Klein A; Kiliç E;
    Invest Ophthalmol Vis Sci; 2016 Apr; 57(4):2232-9. PubMed ID: 27116551
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Correlation of Gene Mutation Status with Copy Number Profile in Uveal Melanoma.
    Yavuzyigitoglu S; Drabarek W; Smit KN; van Poppelen N; Koopmans AE; Vaarwater J; Brands T; Eussen B; Dubbink HJ; van Riet J; van de Werken HJ; Beverloo B; Verdijk RM; Naus N; Paridaens D; Kilic E; de Klein A;
    Ophthalmology; 2017 Apr; 124(4):573-575. PubMed ID: 27916271
    [No Abstract]   [Full Text] [Related]  

  • 31. Marked genetic differences between BRAF and NRAS mutated primary melanomas as revealed by array comparative genomic hybridization.
    Lázár V; Ecsedi S; Vízkeleti L; Rákosy Z; Boross G; Szappanos B; Bégány A; Emri G; Adány R; Balázs M
    Melanoma Res; 2012 Jun; 22(3):202-14. PubMed ID: 22456166
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular profiling of primary uveal melanoma: results of a Polish cohort.
    Kowalik A; Karpinski P; Markiewicz A; Orlowska-Heitzman J; Romanowska-Dixon B; Donizy P; Hoang MP
    Melanoma Res; 2023 Apr; 33(2):104-115. PubMed ID: 36719926
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mutations in g protein encoding genes and chromosomal alterations in primary leptomeningeal melanocytic neoplasms.
    Küsters-Vandevelde HV; van Engen-van Grunsven IA; Coupland SE; Lake SL; Rijntjes J; Pfundt R; Küsters B; Wesseling P; Blokx WA; Groenen PJ
    Pathol Oncol Res; 2015 Apr; 21(2):439-47. PubMed ID: 25315378
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Paired comparisons of mutational profiles before and after brachytherapy in asian uveal melanoma patients.
    Lee WS; Lee J; Choi JJ; Kang HG; Lee SC; Kim JH
    Sci Rep; 2021 Sep; 11(1):18594. PubMed ID: 34545149
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Iris and Ciliary Body Melanocytomas Are Defined by Solitary GNAQ Mutation Without Additional Oncogenic Alterations.
    Solomon DA; Ramani B; Eiger-Moscovich M; Milman T; Uludag G; Crawford JB; Phan I; Char DH; Shields CL; Eagle RC; Bastian BC; Bloomer MM; Pekmezci M
    Ophthalmology; 2022 Dec; 129(12):1429-1439. PubMed ID: 35835335
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Integrated Genomic Classification of Melanocytic Tumors of the Central Nervous System Using Mutation Analysis, Copy Number Alterations, and DNA Methylation Profiling.
    Griewank KG; Koelsche C; van de Nes JAP; Schrimpf D; Gessi M; Möller I; Sucker A; Scolyer RA; Buckland ME; Murali R; Pietsch T; von Deimling A; Schadendorf D
    Clin Cancer Res; 2018 Sep; 24(18):4494-4504. PubMed ID: 29891723
    [No Abstract]   [Full Text] [Related]  

  • 37. Uveal Melanoma Nuclear BRCA1-Associated Protein-1 Immunoreactivity Is an Indicator of Metastasis.
    Szalai E; Wells JR; Ward L; Grossniklaus HE
    Ophthalmology; 2018 Feb; 125(2):203-209. PubMed ID: 28823399
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical significance of immunohistochemistry for detection of BAP1 mutations in uveal melanoma.
    Koopmans AE; Verdijk RM; Brouwer RW; van den Bosch TP; van den Berg MM; Vaarwater J; Kockx CE; Paridaens D; Naus NC; Nellist M; van IJcken WF; Kiliç E; de Klein A
    Mod Pathol; 2014 Oct; 27(10):1321-30. PubMed ID: 24633195
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Systematic genomic and translational efficiency studies of uveal melanoma.
    Johnson CP; Kim IK; Esmaeli B; Amin-Mansour A; Treacy DJ; Carter SL; Hodis E; Wagle N; Seepo S; Yu X; Lane AM; Gragoudas ES; Vazquez F; Nickerson E; Cibulskis K; McKenna A; Gabriel SB; Getz G; Van Allen EM; 't Hoen PAC; Garraway LA; Woodman SE
    PLoS One; 2017; 12(6):e0178189. PubMed ID: 28594900
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular Genetics of Conjunctival Melanoma and Prognostic Value of
    van Poppelen NM; van Ipenburg JA; van den Bosch Q; Vaarwater J; Brands T; Eussen B; Magielsen F; Dubbink HJ; Paridaens D; Brosens E; Naus N; de Klein A; Kiliç E; Verdijk RM
    Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34071371
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.